MedPath
NMPA Approval

Ceftriaxone Sodium for Injection

国药准字H20023340

August 16, 2024

Drug Information

注射用头孢曲松钠

注射剂

0.5g(按C₁₈H₁₈N₈O₇S₃计)

化学药品

August 16, 2024

Company Information

Applicant Company

海南省海口市秀英区南海大道192号

Manufacturing Company

海南省海口市秀英区南海大道192号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.